@Madrigal__ Profile picture

Luca Romagnoli

@Madrigal__

Translating Cell Therapy advances into clinical applications and (hopefully) new treatment options for patients.

Similar User
Geoff Lomax photo

@Geoff_Lomax

Sven Kili photo

@Biosurgerysven

Accellix photo

@accellix

Newcastle Advanced Therapies photo

@ATMPNewcastle

James L. Sherley photo

@asymmetrex

Henry McCusker photo

@henryw09

Luca Romagnoli Reposted

Hey guys, wanna feel old? I'm 40. You're welcome.


"The evolving role of CMOs in the clinical translation of Advanced Therapy Medicinal Products". Post on Linkedin: goo.gl/2S44ZW


Encouraging results of CAR-T cell therapy in glioblastoma from H.Okada. 6/6 patients treated showed expansion of infused cells. #ISCT2015


EMA just released "Draft reflection paper on classification of #advanced #therapy medicinal products" goo.gl/5gerSL


F. Barry at #TERMIS14: "The only commercially viable models in cell therapy will be allogeneic." I don't think everybody would agree.


R. Aras at #TERMIS14 "Think about competition: if no one else around you is doing it, that probably means it's not relevant".


Report from the Commission to the European Parliament on the implementation of #Advanced #Therapies regulation. goo.gl/E0p4Ax


Excited to present at @Unistem2014 in Ferrara! More than 400 students curious to know more about #stemcells !


Very good vibes from today's Alliance for Advanced Therapies Summit. Several key players look confident and ready to address challenges.


I'm at the #VIC2013 Cell Therapy Manufacturing in Brussels. Great presentations so far.


B.Siegel now speaking about the impact of patient advocacy movement in reg med. #WCRM2013


G.Rosskamp "Patients are more price-sensitive than has been recognized and choose "inferior" product if reg med too expensive. #WCRM2013


G.Rosskamp "Having any revenue (even small amounts) encourages investors and can facilitate raising equity and debt financing" #WCRM2013


G.Rosskamp (Northwest Biotherapeutics) presenting lessons learned in #celltherapy industry #WCRM2013


P.Macchiarini: "Current failures in regen approaches may be due to hypoxic substrate not providing good environment" #WCRM2013


P.Macchiarini "Targeting exact number and type of cells for each scaffold surface is key. Need mathematical approach." #WCRM2013


P.Macchiarini now presenting. "#Stemcells do not represent a danger to anybody if correctly manipulated" #WCRM2013


I'm tweeting from the World Conference on Regenerative Medicine in Leipzig #WCRM2013


United States Trends
Loading...

Something went wrong.


Something went wrong.